Username Password
S&P 500: 1,319.94 Change: +0.56%
Neurodoc
P&P Score: 99.33   Points: 80.19   Accuracy: 47.42%   Average Pick Score: 0.30   Annual Return: 10.00% (36.01% since 10/18/08)  

Neurodoc's Blog : Getting on the MAPP

Date September 11, 2009    Comments Comments (0)    Recommended (43)   
Bookmark and Share
Abuse this post  Report Abuse
Please report this as abuse only if you believe it violates People And Picks  Terms of Use
You must log in to send an abuse report.
Share ThisShare This
MAPP's Levadex to be presented at the IHS conference--looks very promising for migraine as alternative to triptans. See www.mappharma.com.

(I'm looking forward to my "biggest loser" not being that!)

Happy investing. JW


Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.
Sponsored Links